The first export of MN Pharmaceuticals was to Algeria in 1988. In the subsequent years the number of export countries increased to 33 with 26,5 million units.
Mustafa Nevzat İlaç Sanayii A.Ş. registered its name as MN Pharmaceuticals abroad in 2003.
Currently, Gensenta has six licensed products on sale in the US market; this number will increase with the addition of new products under registration.